TY - JOUR
T1 - Interferon-induced retinopathy in asymptomatic cancer patients
AU - Esmaeli, Bita
AU - Koller, Charles
AU - Papadopoulos, Nicholas
AU - Romaguera, Jorge
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Objectives: Interferon-induced ocular complications, including retinal ischemia and ischemic optic neuropathy, can be associated with significant visual loss. We report three cases of asymptomatic ischemic retinopathy in cancer patients receiving interferon. Design: Retrospective, interventional, noncomparative small case series. Methods: Retrospective review of the medical records and fundus photographs. Results: Interferon-induced ischemic retinopathy can occur in asymptomatic cancer patients. The retinal changes are usually reversible with discontinuation of interferon therapy. Conclusions: These three cases underscore the importance of dilated funduscopic examination at baseline and during follow-up, at least every 3 months, for all cancer patients receiving interferon to identify retinal toxicity at its earliest stages. A prospective study evaluating the incidence and severity of interferon retinopathy in cancer patients would be prudent.
AB - Objectives: Interferon-induced ocular complications, including retinal ischemia and ischemic optic neuropathy, can be associated with significant visual loss. We report three cases of asymptomatic ischemic retinopathy in cancer patients receiving interferon. Design: Retrospective, interventional, noncomparative small case series. Methods: Retrospective review of the medical records and fundus photographs. Results: Interferon-induced ischemic retinopathy can occur in asymptomatic cancer patients. The retinal changes are usually reversible with discontinuation of interferon therapy. Conclusions: These three cases underscore the importance of dilated funduscopic examination at baseline and during follow-up, at least every 3 months, for all cancer patients receiving interferon to identify retinal toxicity at its earliest stages. A prospective study evaluating the incidence and severity of interferon retinopathy in cancer patients would be prudent.
UR - http://www.scopus.com/inward/record.url?scp=0035041227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035041227&partnerID=8YFLogxK
U2 - 10.1016/S0161-6420(01)00546-2
DO - 10.1016/S0161-6420(01)00546-2
M3 - Article
C2 - 11320013
AN - SCOPUS:0035041227
SN - 0161-6420
VL - 108
SP - 858
EP - 860
JO - Ophthalmology
JF - Ophthalmology
IS - 5
ER -